期刊文献+

结核分枝杆菌早期分泌蛋白CFP-10的原核表达 被引量:1

Prokryotic expression of CFP-10 protein of Mycobacterium tuberculosis
原文传递
导出
摘要 目的构建结核分枝杆菌(MTB)早期分泌蛋白CFP-10原核表达载体并进行诱导表达。方法通过PCR技术从结核分枝杆菌H37Rv基因组中扩增出lhp基因片段,目的基因片段克隆至表达载体pET-32a(+),构建pET-32a—CFP-10重组表达质粒,将其转化E.coliBL21(DE3),经IPTG诱导表达。结果成功地构建原核表达载体pET-32a—CFP-10,以重组体转化E.coliBL21(DE3),成功进行诱导表达。结论成功构建CFPl0的原核表达质粒,高效表达目的蛋白CFP-10,为进-步研究其免疫学功能奠定了基础。 Objective To construct recombinant plasmid containing CFP-IO gene of Mycobacteri- um tuberculosis(MTB). Methods The gene fragment of CFP-IO was amplified by PCR from Mycobacteri- um tuberculosis H37Rv genomic DNA and cloned to pET-32a( + ) vector. The recombinant plasmid pET- 32a-CFP-lO was transformed into E. coli BL21 (DE3) and induced by IPTG. Results CFP-10 gene frag- ment was amplified from genomie DNA of Mycobacterium tuberculosis H3~ Rv strain, and the pET-32a( + ) prokaryotic recombinant plasmid was constructed successfully. The recombinant protein was expressed with the induction of IPTG. Conclusions The prokaryotic expression vector for CFP-IO was successfully constructed and the recombinant protein was highly expressed in E. coli BL21 (DE3) , which lays a foundation for its subseauent immunological function study.
机构地区 解放军第三
出处 《中国医师杂志》 CAS 2013年第3期324-327,共4页 Journal of Chinese Physician
关键词 分枝杆菌 结核 遗传学 细菌蛋白质类 遗传学 遗传载体 Mycobacterium tuberculosis/genetics Bacterial proteins/genetics Genetic vectors
  • 相关文献

参考文献11

  • 1WHO. Global tuberculosis control : surveillance, planning, finan- cing. WHO report ,2008,729.
  • 2Brewer TF, Heymann SJ. To control and beyond: moving towards eliminating the global tuberculosis threat. J Epidemiol Community Health,2004,58(10) :822-825.
  • 3李峤珂,吴雪琼,阳幼荣,梁艳,张俊仙,李楠,叶丽萍,梁建琴,王安生,张广宇,张涛,王兰.CFP10/ESAT6融合蛋白-ELISPOT方法的建立及其在结核分枝杆菌感染诊断中的应用价值[J].中国人兽共患病学报,2010,26(6):551-554. 被引量:16
  • 4Arend SM, Geluk A, van Meijgaarden KE, et al. hmigenic e-quivalence of human T-cell responses to Mycobacterium tuberculo- sis-specific RDl-encoded protein antigens ESAT-6 and culture fil- trate protein 10 and to mixtures of synthetic peptides. Infect Im- mun ,2000,68(6) :3314-3321.
  • 5Woodworth JS, Fortune SM, Behar SM. Bacterial protein secretion is required for priming of CI)8 + T cells specific for the Mycobac- terium tuberculosis antigen CFP10. Infect Immun,2008,76 (9) : 4199-4205. doi: 10.1128/IAI. 00307498.
  • 6Salam N, Gupta S, Sharma S, et al. Protective immunity to Myco- bacterium tuberculosis infection by chemokine and cytokine condi- tioned CFP-IO differentiated dendritic cells. PLoS One,2008,3 (8) : e2869, doi : 10. 1371/journal. pone. 0002869.
  • 7Parker JN, Pfister LA, Quenelle D, et al. Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates. Vaccine,2006,24(10) :1644-1652.
  • 8Klucar P, Barnes PF, Kong Y, et al. Vaccination strategies to en-hance local immunity and protection against Mycobaeteriun tuber- culosis. Vaccine ,2009,27 ( 12 ) : 1816-1824.
  • 9Lin CW, Su IJ, Chang JR, et al. Recombinant BCG coexpressing Ag85B, CFP10, and ixlterleukin-12 induces multifunctional Thl and memory T cells in mice. APMIS, 2012,120( 1 ) :72-82. doi: 10.1111/j. 1600 -0463. 2011. 02815. x.
  • 10Skjot RL, Oettinger T, Rosenkrands I, et al. Comparative evalu- ation of low-molecular-mass proteins from Mycobacterium tuber- culosis identifies members of the ESAT-6 family as immunodomi- nant T-cell antigens. Infect Immun,2000,68(1) :214-220.

二级参考文献13

  • 1李娟,吴雪琼,张俊仙,李香兰,张灵霞,梁建琴.结核分枝杆菌CFP10-ESAT6融合蛋白在大肠杆菌中的高效表达[J].中国防痨杂志,2004,26(4):204-208. 被引量:8
  • 2Arend SM,Thijsen SFT,Leyten EMS,et al.Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts[J].Am J Respir Crit Care Med,2007,175:618-627.
  • 3Lalvani A,Pathan AA,McShane H.Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells[J].Am J Respir Crit Care Med,2001,163:824-828.
  • 4Shams H,Weis SE,Klucar P.Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection[J].Am J Respir Crit Care Med,2005,172:1161-1168.
  • 5Hill PC,Jackson-Sillah D,Fox A,et al.ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of Mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia[J].J Clin Microbiol,2005,43:2070-2074.
  • 6Gordon SV,Brosch R,Billault A,et al.Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays[J].Mol Microbiol,1999,32:643-655.
  • 7Behr MA,Wilson MA,Gill WP,et al.Comparative genomics of BCG vaccines by whole-genome DNA microarray[J].Science,1999,284:1520-1523.
  • 8Codecasa L,Mantegani P,Galli L,et al.An in-house RD1-based enzyme-linked immunospot gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection[J].J Clin Microbiol,2006,44:1944-1950.
  • 9Dheda K,Udwadia ZF,Huggett JF,et al.Utility of the antigen-specific interferon-γ assay for the management of tuberculosis[J].Current Opinion in Pulmonary Medicine,2005,11:195-202.
  • 10Chapman AL,Munkanta M,Wilkinson KA,et al.Rapid detection of active and latent tuberculosis infection in HIV positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells[J].AIDS,2002,16:2285-2293.

共引文献15

同被引文献13

  • 1刘必胜,刘新垣,钱程.构建多顺反子表达载体的有效工具——FMDV 2A[J].生物工程学报,2007,23(5):765-769. 被引量:12
  • 2Kaufmann SH. Tuberculosis vaccines: time to think about the next generation [ J ]. Semin Immunol, 2013,25 (2) : 172-181.
  • 3Schuck SD, Mueller H, Kunitz F, et al. Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection [J]. PLoS One, 2009,4(5) :e5590.
  • 4Reece ST, Nasser-Eddine A, Dietrich J, et al. Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing laten- cy associated antigens[J]. Vaccine, 2011,29(47) :8740-8744.
  • 5Mir FA, Kaufmann SH, Eddine AN. A multicistronic DNA vac- cine induces significant protection against tuberculosis in mice and offers flexibility in the expressed antigen repertoire [ J ]. Clin Vac- cine Immunol, 2009,16 (10) : 1467-1475.
  • 6Mollenkopf HJ, Grode L, Mattow J, et al. Application of myco- bacterial proteomics to vaccine design : improved protection by My- cobacterium bovis BCG prime-Rv3407 DNA boost vaccination a- gainst tuberculosis [ J ]. Infect Immun ,2004,72 ( 11 ) :6471-6479.
  • 7de Souza GA, Leversen NA, Mtden H, et al. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway [ J ]. J Proteomics, 2011,75 ( 2 ) :502-510.
  • 8Downing K J, Betts JC, Young DI, et al. Global expression profi- ling of strains harbouring null mutations reveals that the five rpf- like genes of Mycobaeterium tuberculosis show functional redun- dancy[J]. Tuberculosis (Edinb) ,2004,84(3-4) :167-179.
  • 9Kaufmann SH, Hnssey G, Lambert PH. New vaccines for tuber- culosis[ J]. Lancet, 2010,375 (9731) :2110-2119.
  • 10Jungblut PR, Schaible UE, Mollenkopf H J, et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacte- rium bovis BCG strains : towards functional genomics of microbial path ogens [ J ]. Mol Microbiol, 1999,33 ( 6 ) : 1103 -1117.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部